Blood pressure regulation
blood pressure regulation diagram RAAS baroreceptor

Summary : This figure presents a comprehensive overview of the multifactorial causes and mechanisms underlying blood pressure (BP) elevation and hypertension, organised as overlapping Venn diagrams. It categorises risk factors into genetic, behavioural, environmental, and socio-economic/psychosocial domains, and details the physiological mechanisms (renal, hormonal, neural, vascular) that mediate BP regulation. venn diagram / conceptual illustration: # Main Domains : • Genetic factors: Biological sex, BP-associated SNPs, monogenic forms of hypertension, epigenetic and foetal programming. • Behavioural factors: Physical activity, sedentary behaviour, sleep quality/quantity, dietary patterns, sodium and potassium intake, obesity, alcohol consumption, drugs/substances that increase BP. • Environmental factors: Geopolitical status, noise pollution, air pollution, climate. • Socio-economic and psychosocial factors: Stress, low socio-economic status, social deprivation, healthcare access, gender identity/roles/norms, gender-based violence, discrimination. # Physiological Mechanisms (Central Overlapping Circles) : ## Renal mechanisms : • Salt sensitivity • Pressure-natriuresis • RAAS (Renin-Angiotensin-Aldosterone System) • Renal ischaemia ## Hormonal mechanisms : • RAAS • Endothelin system • Sex hormones ## Neural mechanisms : • Autonomic nervous system (SNS/PNS) • Baroreceptor reflex ## Vascular mechanisms : • Endothelial dysfunction • Small artery remodelling • Large artery stiffness # Central Illustration : • At the centre, a cartoon of a man and woman symbolises the affected population. # Design Encodings : • Each domain is represented by a large, coloured circle with overlapping regions for mechanisms. • Mechanisms are shown as smaller, darker circles overlapping the main domains. • Bulleted lists within each circle detail specific factors/mechanisms. • ESC logo at bottom right. # Analysis : • The figure visually emphasises that hypertension is a complex, multifactorial condition resulting from the interplay of genetic, behavioural, environmental, and socio-economic/psychosocial factors. • Physiological mechanisms (renal, hormonal, neural, vascular) are central and overlap with all domains, indicating their integrative role in BP regulation. • The central placement of the affected individuals highlights the human impact and the need for a holistic approach to hypertension prevention and management. • No quantitative data or statistical relationships are presented; the figure is conceptual and descriptive.

A medical infographic and pathophysiology diagram summarizing the long-term impact of COVID-19 on blood pressure based on a retrospective cohort study. The upper portion illustrates the cellular mechanism where SARS-CoV-2 leads to the downregulation of ACE-2 receptors, causing RAAS dysregulation (increased Ang II binding to AT1R and decreased Ang 1-7 binding to Mas receptors), endothelial dysfunction, and inflammation. The left panel details the 'Settings and participants' section, noting a study of 5,355 eligible patients with documented BP pre- and post-infection. The central 'BP change' panel shows quantitative increases in systolic blood pressure (SBP from 126.90 to 136.99 mmHg) and diastolic blood pressure (DBP from 80.54 to 86.49 mmHg), highlighted with red upward arrows. The right panel lists clinical predictors of BP changes, including smoking, diabetes, cardiovascular events, hypertension, and age, accompanied by illustrative icons. The graphic integrates clinical data with biological mechanisms to demonstrate the cardiovascular sequelae of COVID-19.

This medical diagram illustrates the central autonomic network and the neural pathways of the brain-heart interaction, specifically highlighting the baroreceptor reflex. The figure is divided into four anatomical levels: heart, spinal cord, medulla, and forebrain. In the forebrain level, a coronal cross-section identifies the anterior cingulate cortex, insular cortex, thalamus, hypothalamus, and the amygdaloid nuclear complex. A sagittal view above it highlights the medial prefrontal cortex and anterior cingulate cortex. The medulla section depicts the nucleus of the solitary tract (NTS), nucleus ambiguus, and ventrolateral medulla. The spinal cord section highlights the intermediolateral cell column. Red arrows trace the baroreceptor reflex pathway: afferent signals originate from the heart, enter the medulla via the NTS, and relay through various brainstem and forebrain nuclei to regulate sympathetic and parasympathetic outflow. This diagram demonstrates the hierarchical organization of homeostatic blood pressure control and the neuroanatomical structures facilitating autonomic regulation in humans.

This pathophysiology diagram illustrates the mechanism of action of imidazoline receptor agonists on blood pressure regulation. The visual is divided into a sagittal brain anatomical diagram and a secondary physiological flowchart. On the left, the diagram highlights the 'I1 imidazoline receptors' located within the Rostral Ventrolateral Medulla (RVLM) of the brainstem, situated inferior to the cerebrum and anterior to the cerebellum. Below this, three pharmacological agents—Clonidine, Moxonidine, and Rilmenidine—are listed as imidazole agonists that target these receptors. To the right, a downward flowchart depicts the systemic consequences of receptor activation: stimulation of the RVLM leads to the 'Inhibition of sympathetic nerve activity,' followed by the 'Inhibition of norepinephrine' release. This progression results in 'Decreased vasoconstriction,' visually represented by an illustration of a dilated blood vessel with reduced smooth muscle tension. The final clinical outcome is identified as 'Reduced blood pressure.' The content is designed for intermediate medical education, focusing on neuropharmacology and cardiovascular physiology.

| Vasoconstrictors | Vasodilators |
|---|---|
| Angiotensin II | Prostaglandins |
| Catecholamines (α-adrenergic) | Kinins (bradykinin) |
| Endothelin | Nitric oxide (NO) |
| Thromboxane | β-adrenergic stimulation |
| Leukotrienes |


| Mechanism | Timeframe | Primary Effect |
|---|---|---|
| Baroreceptor reflex | Seconds | Heart rate and vascular tone |
| Catecholamines (sympathetic) | Seconds-minutes | HR, contractility, vasoconstriction |
| RAAS (Angiotensin II) | Minutes-hours | Vasoconstriction + aldosterone release |
| Aldosterone (ENaC) | Hours-days | Sodium/water retention, blood volume |
| ANP/BNP | Hours | Natriuresis, vasodilation |
| Renal pressure-natriuresis | Days | Long-term volume set point |
Give it in exam writing form with neural short term intermediate and long term regulation
vasomotor centre medulla cardiovascular regulation diagram

An anatomical and pathophysiology diagram illustrating the central autonomic regulation sites (CARS) within a mid-sagittal section of the human brain and spinal cord. The diagram maps 14 numbered CARS sites involved in cardiovascular control, including the prefrontal cortex, hypothalamus, and brainstem nuclei. In the medulla (CARS site 1), organotopic neurons are identified as regulating specific targets: skin (Skn), skeletal muscle (Mcl), visceral/gut (Gut), catecholamine release (Cat), and renal (Ren) systems. Key physiological pathways shown include the common tonic parasympathetic supply via the vagus nerve (X) and glossopharyngeal nerve (IX) to the heart, and the common tonic vasomotor sympathetic supply descending through the spinal cord (T1–T12). The diagram links these central pathways to major peripheral vascular beds (cutaneous, skeletal muscle, and visceral) and the heart. Educational features include representative ECG and arterial blood pressure (BP) waveforms, alongside anatomical landmarks like the coeliac ganglion, highlighting the integrated neural mechanisms of orthostatic blood pressure defense and cardiac chronotropic/inotropic regulation.

This composite diagnostic image displays functional magnetic resonance imaging (fMRI) data mapping cardiovascular regulatory centers in the human hypothalamus and brainstem. Panel (a) shows a hypothalamic cluster encompassing the paraventricular nucleus (PVN) and posterior hypothalamic area (PH) in a coronal view (y=-5). Panels (b), (c), and (d) utilize axial slices of the medulla oblongata to demonstrate connectivity changes during lower body negative pressure (LBNP). Panel (b) illustrates increased functional connectivity between the hypothalamus and a cluster in the lateral medulla (z=-51), including the rostral ventrolateral medulla (RVLM) and nucleus ambiguus (Amb), represented by t-values. Panel (c) shows a matched independent component (mICA) probability map identifying this functional cluster. Panel (d) reveals increased functional connectivity within the medulla (z=-57), specifically targeting the nucleus of the solitary tract (NTS), as further detailed in the accompanying anatomical diagram. The color scales indicate statistical significance (t-values from 1.5 to 6.0) or mixture model (MM) probability (0.5 to 1.0). This material serves to illustrate central baroreflex pathways and autonomic nervous system regulation.
| Event | Response |
|---|---|
| ↑ BP → vessel wall stretches | ↑ baroreceptor firing |
| Afferents → Nucleus Tractus Solitarius (NTS) | NTS activates vasodilator area + cardioinhibitory center |
| ↓ Sympathetic outflow + ↑ Parasympathetic outflow | ↓ HR, ↓ contractility, vasodilation |
| Net result | BP falls back to normal |
| Reflex | Trigger | Effect on BP |
|---|---|---|
| Bainbridge reflex | ↑ venous return / atrial stretch | ↑ HR → ↑ BP |
| Bezold-Jarisch reflex | Ventricular C-fiber activation (e.g., ischemia, serotonin) | Bradycardia + vasodilation |
| Axon reflex | Local tissue injury | Local vasodilation |
| Higher cortical influences | Pain, emotion, exercise | ↑ or ↓ BP via hypothalamus → VMC |

| Mechanism | Onset | Duration | Effector | Max Strength |
|---|---|---|---|---|
| Baroreceptor reflex | Seconds | Minutes | Heart + vessels | Moderate |
| Chemoreceptor reflex | Seconds | Minutes | Vessels | Moderate |
| CNS ischemic response | Seconds | Minutes | Vessels | Very high |
| Adrenal medulla | Minutes | 30–60 min | Heart + vessels | Moderate |
| Capillary fluid shift | 10–30 min | Hours | Blood volume | Moderate |
| Stress relaxation | 30 min | Hours | Vascular tone | Moderate |
| RAAS (acute) | 15–30 min | Hours | Vessels + kidney | High |
| Vasopressin (ADH) | 15–30 min | Hours | Vessels + kidney | Moderate |
| RAAS + Aldosterone (chronic) | Hours | Days | Kidney (Na⁺ balance) | High |
| Pressure natriuresis | Hours | Indefinite | Kidney (ECF volume) | Infinite |
| ANP/BNP | Hours | Days | Kidney + vessels | Moderate |
Key exam point: The renal-body fluid system is the only mechanism with infinite gain - it never resets or adapts. Long-term BP is therefore ultimately determined by the kidneys. All other mechanisms are temporary buffers.
Give it in exam writing form with neural short term intermediate and long term regulation
BP = Cardiac Output (CO) × Peripheral Vascular Resistance (PVR) CO = Heart Rate × Stroke Volume
| Area | Location | Function |
|---|---|---|
| Vasoconstrictor area (C1/RVLM) | Rostral VLM | Tonically active; sends sympathetic impulses via spinal cord → NE → α1 receptors → vasoconstriction |
| Vasodilator area | Caudal VLM | Inhibits vasoconstrictor area → net vasodilation |
| Cardioinhibitory area | Dorsal vagal nucleus / NA | Parasympathetic → ↓ HR |
↑ BP → vessel wall stretch
→ ↑ baroreceptor firing
→ NTS in medulla
→ activates vasodilator area + cardioinhibitory centre
→ ↓ sympathetic outflow + ↑ parasympathetic outflow
→ ↓ HR, ↓ contractility, vasodilation
→ BP returns to normal
↓ BP → ↓ baroreceptor firing
→ vasoconstrictor area disinhibited
→ ↑ sympathetic outflow
→ ↑ HR, ↑ contractility, vasoconstriction
→ BP restored
| Reflex | Trigger | Effect |
|---|---|---|
| Bainbridge reflex | ↑ venous return / atrial stretch | ↑ HR → ↑ CO → ↑ BP |
| Bezold–Jarisch reflex | Ventricular C-fibre activation (ischaemia, toxins) | Bradycardia + vasodilation (↓ BP) |
| Higher centres (hypothalamus, cortex) | Emotion, pain, exercise | ↑ or ↓ BP via VMC |
Juxtaglomerular cells → Renin release
→ Renin cleaves Angiotensinogen (liver) → Angiotensin I
→ ACE (pulmonary endothelium) → Angiotensin II

| Arterial Pressure | Urine Output |
|---|---|
| 50 mmHg | ≈ Zero |
| 100 mmHg | Normal |
| 200 mmHg | 4–6× normal |
↑ BP
→ ↑ renal perfusion pressure
→ ↑ Na⁺ and water excretion (natriuresis + diuresis)
→ ↓ ECF and blood volume
→ ↓ venous return → ↓ CO
→ BP returns to normal set-point
↓ BP → ↓ renal output → ↑ blood volume → ↑ CO → BP rises
| Mechanism | Onset | Duration | Primary Effector | Gain |
|---|---|---|---|---|
| SHORT-TERM | ||||
| Baroreceptor reflex | Seconds | Minutes | Heart + arterioles | Moderate |
| Chemoreceptor reflex | Seconds | Minutes | Arterioles | Moderate |
| CNS ischemic response | Seconds | Minutes | Arterioles | Very high |
| INTERMEDIATE | ||||
| Adrenal medulla (catecholamines) | 20–30 s | 30–60 min | Heart + vessels | Moderate |
| Transcapillary fluid shift | 10–30 min | 1–2 h | Plasma volume | Moderate |
| Stress relaxation | 30 min | Hours | Capacitance vessels | Low |
| RAAS — Ang II (vasoconstriction) | 15–30 min | Hours | Arterioles + kidney | High |
| Vasopressin (ADH) | 15–30 min | Hours | Arterioles + kidney | Moderate |
| LONG-TERM | ||||
| RAAS — Aldosterone (Na⁺ retention) | Hours | Days | Kidney (ENaC) | High |
| Pressure natriuresis/diuresis | Hours | Indefinite | Kidney (ECF vol.) | Infinite |
| ANP/BNP (counter-regulatory) | Hours | Days | Kidney + arterioles | Moderate |
Exam high-yield point: The renal pressure–natriuresis system is the only mechanism with infinite gain and is therefore the ultimate determinant of long-term blood pressure. All short- and intermediate-term mechanisms are buffers that buy time until the renal system reaches equilibrium.